Mantle cell lymphoma-derived cell lines: Unique research tools

Leukemia Research

Volumn 30, Issue 8, 2006, Pages 911-913

  Drexler, Hans G ^a   MacLeod, Roderick A F ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; CELL STRAIN; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; EDITORIAL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LYMPHOMA CELL LINE; MANTLE CELL LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; SPECTRAL KARYOTYPING;

ANIMALS; CELL LINE, TUMOR; CYTOGENETIC ANALYSIS; HUMANS; HYBRID CELLS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, MANTLE-CELL; METAPHASE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLOIDIES;

EID: 33744787874     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.02.015     Document Type: Editorial

References (28)

1. Drexler HG. Guide to leukemia-lymphoma cell lines. Braunschweig; 2005.
2. Sanchez-Izquierdo D., Buchonnet G., Siebert R., Gascoyne R.D., Climent J., Karran L., et al. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood 101 (2003) 4539-4546
3. Rudolph C., Steinemann D., Von Neuhoff N., Gadzicki D., Ripperger T., Drexler H.G., et al. Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519. Cancer Genet Cytogenet 153 (2004) 144-150
4. Ek S., Ortega E., and Borrebaeck C.A. Transcriptional profiling and assessment of cell lines as in vitro models for mantle cell lymphoma. Leuk Res 29 (2005) 205-213
5. de Leeuw R.J., Davies J.J., Rosenwald A., Bebb G., Gascoyne R.D., Dyer M.J., et al. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genet 13 (2004) 1827-1837
6. Rubio-Moscardo F., Climent J., Siebert R., Piris M.A., Martin-Subero J.I., Nielander I., et al. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood 105 (2005) 4445-4454
7. Tagawa H., Karnan S., Suzuki R., Matsuo K., Zhang X., Ota A., et al. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 24 (2005) 1348-1358
8. Drexler H.G., and MacLeod R.A. Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma. Leuk Res 26 (2002) 781-787
9. Melo J.V., Brito-Babapulle V., Foroni L., Robinson D.S., Luzzatto L., and Catovsky D. Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. Int J Cancer 38 (1986) 531-538
10. Orchard J., Garand R., Davis Z., Babbage G., Sahota S., Matutes E., et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 101 (2003) 4975-4981
11. Estrov Z., Talpaz M., Ku S., Harris D., Van Q., Beran M., et al. Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia. Leuk Res 22 (1998) 341-353
12. Medeiros L.J., Estrov Z., and Rassidakis G.Z. Z-138 cell line was derived from a patient with blastoid variant mantle cell lymphoma. Leuk Res 30 (2006) 497-501
13. Camps J., Salaverria I., Garcia M.J., Prat E., Beà S., Pole J.C., et al. Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines. Leuk Res 30 (2006) 923-934
14. Jami J., and Grandchamp S. Karyological properties of human-mouse somatic hybrids. Proc Natl Acad Sci USA 68 (1971) 3097-3101
15. MacLeod R.A., Dirks W.G., Matsuo Y., Kaufmann M., Milch H., and Drexler H.G. Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer 83 (1999) 555-563
16. Drexler H.G., Dirks W.G., Matsuo Y., and MacLeod R.A. False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 17 (2003) 416-426
17. MacLeod R.A., and Drexler H.G. Cytogenetic analysis of cell lines. Methods Mol Biol 290 (2005) 51-70
18. Saltman D.L., Cachia P.G., Dewar A.E., Ross F.M., Krajewski A.S., Ludlam C., et al. Characterization of a new non-Hodgkin's lymphoma cell line (NCEB-1) with a chromosomal (11:14) translocation [t(11:14)(q13;q32)]. Blood 72 (1988) 2026-2030
19. Kuroki T., and Huh N.H. Why are human cells resistant to malignant cell transformation in vitro?. Jpn J Cancer Res 84 (1993) 1091-1100
20. Jadayel D.M., Lukas J., Nacheva E., Bartkova J., Stranks G., De Schouwer P.J., et al. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519). Leukemia 11 (1997) 64-72
21. Abe M., Nozawa Y., Wakasa H., Ohno H., and Fukuhara S. Characterization and comparison of two newly established Epstein-Barr virus-negative lymphoma B-cell lines. Surface markers, growth characteristics, cytogenetics, and transplantability. Cancer 61 (1988) 483-490
22. Jeon H.J., Kim C.W., Yoshino T., and Akagi T. Establishment and characterization of a mantle cell lymphoma cell line. Br J Haematol 102 (1998) 1323-1326
23. Goy A., Remache Y.K., Gu J., Stewart J., Hayes K.J., Gold D., et al. Establishment and characterization of a new mantle cell lymphoma cell line M-1. Leuk Lymphoma 45 (2004) 1255-1260
24. Zamo A., Ott G., Katzenberger T., Adam P., Parolini C., Scarpa A., et al. Establishment of MAVER-1 cell line, a model for leukemic and aggressive mantle cell lymphoma. Haematologica 91 (2006) 40-47
25. Lai R., McDonnell T.J., O'Connor S.L., Medeiros L.J., Oudat R., Keating M., et al. Establishment and characterization of a new mantle cell lymphoma cell line, Mino. Leuk Res 26 (2002) 849-855
26. Prod'homme T., Drenou B., De Ruyffelaere C., Barbieri G., Wiszniewski W., Bastard C., et al. Defective class II transactivator expression in a B lymphoma cell line. Leukemia 18 (2004) 832-840
27. Daibata M., Kubonishi I., Eguchi T., Yano S., Ohtsuki Y., and Miyoshi I. The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma. Cancer 64 (1989) 1248-1253
28. M'kacher R., Farace F., Bennaceur-Griscelli A., Violot D., Clausse B., Dossou J., et al. Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model. Cancer Genet Cytogenet 143 (2003) 32-38